指南与共识外周血管技术与安全USMRCTPET

EULAR关于影像学在大血管炎临床实践中应用的推荐:2023年更新

EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update.
指南 / 共识 · Ann Rheum Dis · 2024-05-15

2023年EULAR更新推荐基于系统文献综述和新证据,由14国24名专家形成3条总体原则和8条推荐;疑似巨细胞动脉炎患者超声列为一线影像检查并须包括腋动脉,大动脉炎首选MRI,随访不常规推荐影像。

要点

  • 疑似巨细胞动脉炎患者超声列为一线影像检查,标准检查须包括腋动脉。
  • 疑似巨细胞动脉炎可以FDG-PET或MRI检查颅内和颅外动脉作为超声替代。
  • 大动脉炎首选MRI,FDG-PET、CT或超声为替代选择。

核心结论

  • 2023年EULAR推荐为影像学在大血管炎诊断和评估中的作用提供最新指导。

研究设计与样本

  • 基于系统文献综述更新证据,由14个国家24名医师、卫生专业人员和患者组成工作组,基于证据和专家意见迭代更新至投票达成共识,推荐等级经匿名投票确定一致性。

诊断标准与关键数值

  • 疑似巨细胞动脉炎:超声推荐为一线影像检查,标准检查应包括腋动脉。
  • 疑似巨细胞动脉炎:FDG-PET或MRI检查颅内和颅外动脉可作为超声的替代。
  • 大动脉炎:MRI为首选影像方法,FDG-PET、CT或超声为替代。
  • 随访:不常规推荐影像学检查。
  • 疑似复发:超声、FDG-PET或MRI可用于评估血管异常,尤其当实验室炎症标志物不可靠时。

临床应用与阅片要点

  • 疑似巨细胞动脉炎时,超声作为一线影像检查,标准检查须包括腋动脉。
  • 无法行超声时,可选用FDG-PET或MRI检查颅内和颅外动脉。
  • 大动脉炎影像评估首选MRI,FDG-PET、CT或超声为替代选择。
  • 不常规推荐影像随访;疑似复发且实验室炎症标志物不可靠时,可用超声、FDG-PET或MRI评估血管异常。
  • 长期监测结构损伤可用MR血管成像、CT血管成像或超声,尤其关注既往血管炎症部位。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To update the EULAR recommendations for the use of imaging modalities in primary large vessel vasculitis (LVV).

METHODS: A systematic literature review update was performed to retrieve new evidence on ultrasound, MRI, CT and [18F]-fluorodeoxyglucose positron emission tomography (FDG-PET) for diagnosis, monitoring and outcome prediction in LVV. The task force consisted of 24 physicians, health professionals and patients from 14 countries. The recommendations were updated based on evidence and expert opinion, iterating until voting indicated consensus. The level of agreement was determined by anonymous votes.

RESULTS: Three overarching principles and eight recommendations were agreed. Compared to the 2018 version, ultrasound is now recommended as first-line imaging test in all patients with suspected giant cell arteritis, and axillary arteries should be included in the standard examination. As an alternative to ultrasound, cranial and extracranial arteries can be examined by FDG-PET or MRI. For Takayasu arteritis, MRI is the preferred imaging modality; FDG-PET, CT or ultrasound are alternatives. Although imaging is not routinely recommended for follow-up, ultrasound, FDG-PET or MRI may be used for assessing vessel abnormalities in LVV patients with suspected relapse, particularly when laboratory markers of inflammation are unreliable. MR-angiography, CT-angiography or ultrasound may be used for long-term monitoring of structural damage, particularly at sites of preceding vascular inflammation.

CONCLUSIONS: The 2023 EULAR recommendations provide up-to-date guidance for the role of imaging in the diagnosis and assessment of patients with LVV.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Dejaco C, Ramiro S, Bond M, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update. Ann Rheum Dis. 2024. PMID: 37550004. doi:10.1136/ard-2023-224543

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。